202 related articles for article (PubMed ID: 10066068)
1. Cyclin D1 in breast cancer.
Barnes DM; Gillett CE
Breast Cancer Res Treat; 1998; 52(1-3):1-15. PubMed ID: 10066068
[TBL] [Abstract][Full Text] [Related]
2. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
Oyama T; Kashiwabara K; Yoshimoto K; Arnold A; Koerner F
Cancer Res; 1998 Jul; 58(13):2876-80. PubMed ID: 9661905
[TBL] [Abstract][Full Text] [Related]
3. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.
Soslow RA; Carlson DL; Horenstein MG; Osborne MP
Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell-cycle regulator p27 is correlated to the prognosis and ER expression in breast carcinoma patients.
Nohara T; Ryo T; Iwamoto S; Gon G; Tanigawa N
Oncology; 2001; 60(1):94-100. PubMed ID: 11150915
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
[TBL] [Abstract][Full Text] [Related]
7. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
8. Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
Feldt M; Bjarnadottir O; Kimbung S; Jirström K; Bendahl PO; Veerla S; Grabau D; Hedenfalk I; Borgquist S
J Transl Med; 2015 Apr; 13():133. PubMed ID: 25925673
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
Gillett CE; Smith P; Peters G; Lu X; Barnes DM
J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
[TBL] [Abstract][Full Text] [Related]
10. [Cell cycle regulators as prognostic factors of breast cancers].
Ohta T; Fukuda M
Nihon Rinsho; 2000 Apr; 58 Suppl():448-53. PubMed ID: 11026032
[No Abstract] [Full Text] [Related]
11. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
13. [Expression of PTEN protein and its correlation with p27kip1 and cyclin D1 expression in primary breast cancer].
Lin Q; Zhuang YZ; Xu DP; Ye JX; Chen PQ
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):246-9. PubMed ID: 12839686
[TBL] [Abstract][Full Text] [Related]
14. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA
Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma.
Hui AM; Li X; Shi YZ; Takayama T; Torzilli G; Makuuchi M
Clin Cancer Res; 2000 Nov; 6(11):4272-7. PubMed ID: 11106243
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
18. Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis.
Zhu Z; Jiang W; Thompson HJ
Mol Carcinog; 1999 Apr; 24(4):241-5. PubMed ID: 10326860
[TBL] [Abstract][Full Text] [Related]
19. Loss of p16 and p27 is associated with progression of human gastric cancer.
Myung N; Kim MR; Chung IP; Kim H; Jang JJ
Cancer Lett; 2000 May; 153(1-2):129-36. PubMed ID: 10779641
[TBL] [Abstract][Full Text] [Related]
20. Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.
Pignataro L; Sambataro G; Pagani D; Pruneri G
Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):75-85. PubMed ID: 16116829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
